European Urology - Erectile Dysfunction and Premature Ejaculation are the Most Frequently Self-Reported Sexual Concerns: Profiles of 9,536 Men Calling A Helpline
Wednesday, 01 March 2006
Volume 49, Issue 3, Pages 557-563 (March 2006) Abstract -
Objectives:
To describe the range of sexual problems, as reported by men calling a help-line and to investigate factors associated with help seeking behaviour.
read more
|
Comparison of the Cardiovascular Effects of Tamsulosin Oral Controlled Absorption System (OCAS®) and Alfuzosin Prolonged Release (XL)
Wednesday, 01 March 2006
Martin C. Michel, AMC, Amsterdam, The Netherlands, Christopher R. Chapple, Royal Hallamshire Hospital, Sheffield, United Kingdom Objective: The cardiovascular (CV) effects of tamsulosin oral controlled absorption system (OCAS®) 0.4mg were compared with those of alfuzosin prolonged release (XL) 10mg.
read more
|
European Urology - Prevalence of Peyronie's Disease Among Patients With Erectile Dysfunction
Wednesday, 01 March 2006
Volume 49, Issue 3, Pages 564-569 (March 2006) Abstract - Purpose:
To assess the prevalence of Peyronie's disease (PD) among patients with erectile dysfunction (ED).
read more
|
Antegrade versus Retrograde Endopyelotomy for Pelvi-Ureteric Junction (PUJ) Obstruction
Wednesday, 01 March 2006
Objectives: To compare complication and success rates of antegrade and retrograde endopyelotomy performed over 10 years and to define possible risk factors associated with treatment failure.
read more
|
Supratrigonal VVF Repair by Modified O’Connor's Technique: An Experience of 26 Cases
Wednesday, 01 March 2006
Objective: To report the technical modifications of O’Connor's procedure and their outcome in 26 supratrigonal vesico vaginal fistulae.
read more
|
Tension-Free Vaginal Tape (TVT) in Morbidly Obese Patients with Severe Urodynamic Stress Incontinence as Last Option Treatment
Wednesday, 01 March 2006
Objectives: To determine the safety and efficacy of tension-free vaginal tape (TVT) in morbidly obese women with severe urodynamic stress incontinence (USI) as last option treatment.
read more
|
Cost-Consequence Analysis Evaluating the Use of Botulinum Neurotoxin-A in Patients with Detrusor Overactivity Based on Clinical Outcomes Observed at a Single UK Centre
Wednesday, 01 March 2006
Objective: This study aimed to assess the resource utilisation, health benefits and cost-effectiveness of intra-detrusor injections of botulinum neurotoxin-A (BoNT/A) in patients with overactive bladder (OAB).
read more
|
Quality of Life Changes in Patients with Neurogenic versus Idiopathic Detrusor Overactivity after Intradetrusor Injections of Botulinum Neurotoxin Type A and Correlations with Lower Urinary Tract Symptoms and Urodynamic Changes
Wednesday, 01 March 2006
Objective: Little published data exist on the effect of intradetrusor botulinum neurotoxin type A (BoNT/A) on the quality of life (QOL) of patients with overactive bladder. We examined post-BoNT/A QOL changes of patients with neurogenic detrusor overactivity (NDO) in comparison to those with idiopathic detrusor overactivity (IDO), and their correlations with respective changes in lower urinary tract symptoms (LUTS) and urodynamic parameters.
read more
|
Depressed Contractile Responses to Neurokinin A in Idiopathic but not Neurogenic Overactive Human Detrusor Muscle
Wednesday, 01 March 2006
Objective: The role of tachykinins such as neurokinin A in regulating bladder function is unclear, but NK2 receptors seem to mediate contraction in the human bladder and it has been suggested that these peptides may have a role in the pathophysiology of bladder dysfunction. The present study investigates neurokinin receptor-mediated contractility of detrusor muscle in the idiopathic overactive and neurogenic overactive bladder and investigates the neurokinin receptor subtypes involved.
read more
|
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
Wednesday, 01 March 2006
Objectives: To provide tables that allow urologists to easily calculate a superficial bladder cancer patient's short- and long-term risks of recurrence and progression after transurethral resection.
read more
|
Nephron-Sparing Surgery for Renal Cell Carcinoma: Detailed Analysis of Complications Over a 15-Year
Wednesday, 01 March 2006
Purpose: To assess the incidence of complications of conservative renal surgery for renal cell carcinoma in both elective and imperative indications, and its evolution over a 15 year period.
read more
|
Modular Training for Residents with no Prior Experience with Open Pelvic Surgery in Endoscopic Extraperitoneal Radical Prostatectomy
Wednesday, 01 March 2006
Purpose: To establish a teaching program for the performance of endoscopic extraperitoneal radical prostatectomy (EERPE) that would ascertain the safe and efficacious training of residents with no previous experience with open pelvic surgery.
read more
|
Half-Day Urotherapy Improves Voiding Parameters in Children with Dysfunctional Emptying
Wednesday, 01 March 2006
Objectives: Children with voiding dysfunction benefit from intensive bladder emptying re-education; however, hospitalization for such training is not always financially viable or realistic. The aim of this study was to evaluate whether half-day voiding re-education in pairs improved immediate and mid-term voiding parameters.
read more
|
Transperitoneal Laparoscopic Adrenalectomy: Outline of the Preoperative Management, Surgical Approach, and Outcome
Wednesday, 01 March 2006
The laparoscopic approach to the adrenal gland has evolved to be the gold standard for most cases of adrenal conditions requiring surgical treatment. There is general consent about the safety, efficacy, and reproducibility of laparoscopic adrenal surgery. Compared to the open surgery, significant advantages with regard to shorter hospitalization time, decreased postoperative morbidity, improved cosmetics, and quicker convalescence are evident. The anatomic location of the adrenal gland led to the development of various approaches, including lateral transperitoneal, anterior transperitoneal, lateral retroperitoneal, posterior retroperitoneal, and even transthoracic approaches. The lateral transperitoneal approach is the technique most frequently used for laparoscopic adrenalectomy. A large operative field provides good orientation and visualization of familiar landmarks known from open surgery. In particular in the early learning curve this represents an advantage of the transperitoneal laparoscopic approach. This article describes in detail the indications, contraindications, preoperative evaluation, surgical technique, management of intraoperative complications, and outcome after lateral transperitoneal adrenalectomy.
read more
|
Does PSA Velocity Predict Prostate Cancer in Pre-Screened Populations?
Wednesday, 01 March 2006
PSA-driven screening has been applied to a large part of the male population in many countries. An elevated PSA in secondary screens may indicate benign enlargement of the prostate rather than prostate cancer. In such cases the yearly rate of increase of PSA (PSA velocity [PSAV]) may improve the test characteristics of PSA
read more
|
Natural History and Treatment of Bone Complications in Prostate Cancer
Wednesday, 01 March 2006
Bone metastases are highly prevalent in patients with prostate cancer, and they commonly present a therapeutic challenge. The natural history of prostatic bone metastases is characterized by skeletal morbidity, often producing distressing symptoms for individual patients and reducing patient autonomy and mobility. These bone metastases are usually radiologically osteoblastic, but there is also a strong osteolytic component as evidenced by marked increases in bone resorption markers. Malignant bone lesions can reduce the structural integrity of the skeleton, resulting in skeletal complications such as pathologic fracture, spinal cord compression, and severe bone pain, which adversely affect quality of life.
read more
|
2005 Update on Pathology of Prostate Biopsies with Cancer?
Wednesday, 01 March 2006
Objective: To review the diagnostic and prognostic importance of pathologic findings in prostate biopsies.
read more
|
Current Practice in the Management of Superficial Bladder Cancer in the Netherlands and Belgian Flanders: A Survey
Wednesday, 01 March 2006
Objectives: Because there is no national guideline for the diagnosis, therapy and follow up of (superficial) bladder cancer in the Netherlands and Belgium, the actual patient management may differ between urologists. The purpose of this study is to get insight in the current way urologists diagnose, treat and follow patients with superficial bladder cancer.
read more
|
